Trials / Conditions / Neoplasms, Unknown Primary

Neoplasms, Unknown Primary

8 registered clinical trials studyying Neoplasms, Unknown Primary.

Status	Trial	Sponsor	Phase
Unknown	Molecular Analysis of Blood Samples in Standardized Cancer Care Referrals for SCAN and CUP NCT04025970	Christer Ericsson	—
Completed	Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary NCT02628379	Foundation Medicine	—
Completed	Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP NCT01540058	Gustave Roussy, Cancer Campus, Grand Paris	Phase 3
Completed	Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP) NCT01202786	Teva Branded Pharmaceutical Products R&D, Inc.	—
Unknown	Paclitaxel/Carboplatin With or Without Cetuximab in CUP NCT00894569	Heidelberg University	Phase 2
Completed	Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site NCT00193609	SCRI Development Innovations, LLC	Phase 2
Completed	Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site NCT00193622	SCRI Development Innovations, LLC	Phase 2
Completed	Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site NCT00193596	SCRI Development Innovations, LLC	Phase 3